Matthew Martin
-
- NF-κB Signaling Pathways 7
-
- Epigenetics and DNA Methylation 5
- Cancer-related gene regulation 5
- RNA Research and Splicing 5
- RNA modifications and cancer 4
- Glycosylation and Glycoproteins Research 2
- Genomics, phytochemicals, and oxidative stress 2
-
- Cytokine Signaling Pathways and Interactions 5
- Co-authors
- Tao LuMengyao SunAishat MotolaniLakshmi PrabhuWei HanBenlian WangYunlong LiuGuanglong Jiang
- Partner nations
- United StatesFranceCanada
In The Last Decade
Matthew Martin
29 papers receiving 493 citations
Peers
Comparison fields: 5 of 78
- Cancer Research 117
- Molecular Biology 343
- Immunology 78
- Oncology 90
- Neurology 26
Countries citing papers authored by Matthew Martin
This map shows the geographic impact of Matthew Martin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Martin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Martin more than expected).
Fields of papers citing papers by Matthew Martin
This network shows the impact of papers produced by Matthew Martin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Martin. The network helps show where Matthew Martin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Matthew Martin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 6 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 9 | |
| 6 | 2022 | 5 | |
| 7 | 2022 | 5 | |
| 8 | 2021 | 4 | |
| 9 | 2021 | 7 | |
| 10 | 2020 | 28 | |
| 11 | 2020 | 34 | |
| 12 | 2019 | 20 | |
| 13 | 2019 | 12 | |
| 14 | 2017 | 55 | |
| 15 | Targeting microenvironment in cancer therapeutics | 2016 | 2 |
| 16 | 2016 | 30 | |
| 17 | Role of post-translational modification of the Y box binding protein 1 in human cancers | 2015 | 1 |
| 18 | 2015 | 20 | |
| 19 | 2015 | 45 | |
| 20 | 2015 | 57 |
About Matthew Martin
Matthew Martin is a scholar working on Cancer Research, Critical Care and Intensive Care Medicine and Oncology, having authored 30 papers that have together received 497 indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (7 papers), Epigenetics and DNA Methylation (5 papers), Cancer-related gene regulation (5 papers), RNA Research and Splicing (5 papers), Cytokine Signaling Pathways and Interactions (5 papers), RNA modifications and cancer (4 papers), Glycosylation and Glycoproteins Research (2 papers) and Genomics, phytochemicals, and oxidative stress (2 papers). The work is most often cited by research in Cancer Research (117 citations), Molecular Biology (343 citations) and Immunology (78 citations). Matthew Martin has collaborated with scholars based in United States, France and Canada. Frequent co-authors include Tao Lu, Mengyao Sun, Aishat Motolani, Lakshmi Prabhu, Wei Han, Benlian Wang, Yunlong Liu, Wei Han, Guanglong Jiang and Emily Sun.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.